SCHEMBL27768366

SCHEMBL27768366

NC(=O)Oc1ccc(-c2cccc(Oc3ccccc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.47
F10 P00742 4/20 0.47
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
ST14 Q9Y5Y6 1/20 0.47
SCN4A P35499 1/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MCL1 Q07820 2/20 0.43
SCN9A Q15858 9/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CHEK2 O96017 1/20 0.41
PARP10 Q53GL7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27768099 0.83 PARP1 (0.48) MEN1KMT2ASCN9A
SCHEMBL3135703 0.81 MCL1 (0.49) SCN4AMCL1SCN9ANPC1RAB9A
SCHEMBL18335708 0.80 RAB9A (0.58) F2F10PRSS1PRSS2PRSS3
SCHEMBL27768368 0.80 F10 (0.47) F2F10PRSS1PRSS2PRSS3
SCHEMBL13680556 0.77 MEN1 (0.46) MEN1KMT2ASCN9ANPC1RAB9A
SCHEMBL27747196 0.77 MEN1 (0.44) MEN1KMT2AMCL1SCN9ANPC1
SCHEMBL5799799 0.77 PARP10 (0.64) MEN1KMT2ANPC1RAB9APARP10
SCHEMBL16334747 0.76 FFAR4 (0.62)
SCHEMBL3140552 0.76 MCL1 (0.44) SCN4AMCL1SCN9ANPC1RAB9A
SCHEMBL3126744 0.75 SCN9A (0.59) SCN4AMCL1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466710-B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC 2013-05-29 CN disclosed
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed